Docket #: S22-479
A digital health solution for remote assessment of allergic contact dermatitis
Stanford researchers have designed a remote digital health platform to assist diagnosis and management of some inflammatory skin conditions, such as eczema. It allows screening for contact allergies by using a new transdermal adhesive device to deliver contact allergens and carry out epicutaneous patch tests paired with a digital platform and a trained neural network for interpretation of results by using digital images.
This test kit enables testing in a remote setting, such as in a home or a primary care facility rather than in a specialty clinic. This system and method include -an adhesive device, a software, algorithms, and communication tools which detects and interprets skin reactions to allergens using digital images.
Stage of Development
Applications
- Digital Platform for assessing inflammatory skin conditions, such as eczema"
- Remote testing kit that can be administered at home or at a primary care facility or pharmacy
Advantages
- Cost effective and convenient - Can be administered at home or in primary care facility rather than in a specialty clinic
- Improves access to care
- Waterproof allergen panels unlike current panels which require users to refrain from bathing for periods of time (typically 4 days)
Similar Technologies
-
Wearable device to treat hyperhidrosis S16-358Wearable device to treat hyperhidrosis
-
Use of complement inhibition to improve wound healing S22-191Use of complement inhibition to improve wound healing
-
Manipulating mechanical forces to regulate inflammation and control scar formation S11-417Manipulating mechanical forces to regulate inflammation and control scar formation